At close: December 20 at 4:00:01 PM EST
After hours: December 20 at 4:15:57 PM EST
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 9,963 | 1 |
Sales | 138,000 | 4 |
Net Shares Purchased (Sold) | -128,037 | 5 |
Total Insider Shares Held | 1.43M | -- |
% Net Shares Purchased (Sold) | -8.20% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
EDRIS BADREDDIN Chief Operating Officer | Sale at price 41.78 - 42.24 per share. | Direct | 839,336 | Dec 3, 2024 |
ISLAM SAQIB Chief Executive Officer | Sale at price 41.33 - 41.85 per share. | Direct | 2,027,357 | Dec 2, 2024 |
ISLAM SAQIB Chief Executive Officer | Sale at price 40.10 - 42.07 per share. | Direct | 1,988,033 | Sep 3, 2024 |
EDRIS BADREDDIN Chief Operating Officer | Sale at price 40.11 - 42.08 per share. | Direct | 812,954 | Sep 3, 2024 |
MACKAY MARTIN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 29, 2024 |
ISLAM SAQIB Chief Executive Officer | Sale at price 39.40 - 42.09 per share. | Direct | 1,955,113 | Jun 3, 2024 |
HAMBLETON JULIE Director | Sale at price 39.41 - 42.09 per share. | Direct | 186,048 | Jun 3, 2024 |
EDRIS BADREDDIN Chief Operating Officer | Sale at price 39.40 - 42.04 per share. | Direct | 801,372 | Jun 3, 2024 |
LYNCH DANIEL S Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 16, 2024 |
FUHRMAN ALAN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 16, 2024 |
LEWIS-HALL FREDA C Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 16, 2024 |
ALBAN CARLOS Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 16, 2024 |
HAMBLETON JULIE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 16, 2024 |
PICHL DANIEL Officer | Conversion of Exercise of derivative security at price 27.64 per share. | Direct | 414,600 | Feb 16, 2024 |
PICHL DANIEL Officer | Sale at price 50.10 per share. | Direct | 751,550 | Feb 16, 2024 |
ASHAR BHAVESH Officer | Sale at price 43.75 - 49.32 per share. | Direct | 381,411 | Feb 5, 2024 |
PICHL DANIEL Officer | Conversion of Exercise of derivative security at price 27.64 per share. | Direct | 449,150 | Feb 2, 2024 |
PICHL DANIEL Officer | Sale at price 43.81 - 46.44 per share. | Direct | 1,160,362 | Feb 2, 2024 |
WEINSTEIN HERSCHEL S General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 4, 2024 |
ISLAM SAQIB Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 4, 2024 |
NOFI MICHAEL Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 4, 2024 |
SMITH LESLEY MARY Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 4, 2024 |
EDRIS BADREDDIN Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 4, 2024 |
PICHL DANIEL Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 4, 2024 |
ASHAR BHAVESH Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 4, 2024 |
PERIER FRANCIS I JR Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 4, 2024 |
CASSIDY JAMES Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 4, 2024 |
LIN TAI-AN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 4, 2024 |
ISLAM SAQIB Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 30, 2023 |
LIN TAI-AN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Oct 2, 2023 |
HAMBLETON JULIE Director | Sale at price 29.31 per share. | Direct | 70,876 | Jul 19, 2023 |
SMITH LESLEY MARY Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 30, 2023 |
CASSIDY JAMES Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 30, 2023 |
HAMBLETON JULIE Director | Sale at price 26.92 per share. | Direct | 64,603 | Jun 20, 2023 |
LYNCH DANIEL S Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 24, 2023 |
FUHRMAN ALAN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 24, 2023 |
LEWIS-HALL FREDA C Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 24, 2023 |
ALBAN CARLOS Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 24, 2023 |
HAMBLETON JULIE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 24, 2023 |
SCHWARTZ JEFFREY LAWRENCE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 24, 2023 |
SCHWARTZ JEFFREY LAWRENCE Director | Sale at price 28.50 per share. | Indirect | 49,875,000 | Mar 16, 2023 |
HAMBLETON JULIE Director | Sale at price 31.50 per share. | Direct | 34,841 | Mar 15, 2023 |
PICHL DANIEL Officer | Sale at price 31.00 per share. | Direct | 26,598 | Jan 26, 2023 |
WEINSTEIN HERSCHEL S General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 5, 2023 |
ISLAM SAQIB Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 5, 2023 |
NOFI MICHAEL Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 5, 2023 |
SMITH LESLEY MARY Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 5, 2023 |
EDRIS BADREDDIN Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 5, 2023 |
PICHL DANIEL Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 5, 2023 |
ASHAR BHAVESH Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 5, 2023 |
Related Tickers
DAWN Day One Biopharmaceuticals, Inc.
12.79
+2.65%
TARS Tarsus Pharmaceuticals, Inc.
52.91
+1.75%
BPMC Blueprint Medicines Corporation
90.14
+1.36%
IDYA IDEAYA Biosciences, Inc.
25.61
+3.31%
XENE Xenon Pharmaceuticals Inc.
38.63
-0.69%
ASND Ascendis Pharma A/S
136.38
-0.99%
RARE Ultragenyx Pharmaceutical Inc.
44.22
+1.73%
TVTX Travere Therapeutics, Inc.
17.18
-1.26%
NUVL Nuvalent, Inc.
84.22
-0.50%
KYMR Kymera Therapeutics, Inc.
40.66
+3.88%